We are live on
!
Find out more
ACB
Aristotle Capital Boston Portfolio holdings
AUM
$1.61B
1-Year Est. Return
19.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.34%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.49B
AUM Growth
+$274M
(+6.5%)
Cap. Flow
-$202M
Cap. Flow
% of AUM
-4.5%
Top 10 Holdings %
Top 10 Hldgs %
17.39%
Holding
140
New
5
Increased
37
Reduced
95
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eHealth
EHTH
|
+$21.7M |
| 2 |
Box
BOX
|
+$18.8M |
| 3 |
Coherus Oncology
CHRS
|
+$5.41M |
| 4 |
HealthEquity
HQY
|
+$4.81M |
| 5 |
Diamondback Energy
FANG
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evercore
EVR
|
+$19.7M |
| 2 |
PPBI
Pacific Premier Bancorp
PPBI
|
+$18.6M |
| 3 |
Sonos
SONO
|
+$16M |
| 4 |
Advanced Energy
AEIS
|
+$10.8M |
| 5 |
MACOM Technology Solutions
MTSI
|
+$9.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.3% |
| 2 | Technology | 17.03% |
| 3 | Healthcare | 15.26% |
| 4 | Financials | 14.45% |
| 5 | Consumer Discretionary | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Albemarle
ALB
$14.2B
| $8.83M | 0.2% |
60,413
-16,371
| -21% | -$2.63M |
|
|
CDMO
127
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $8.72M | 0.19% |
478,471
+5,170
| +1% | +$85.9K |
|
128
Range Resources
RRC
$9.09B
| $8.43M | 0.19% |
816,458
-111,278
| -12% | -$1.08M |
|
129
iShares Core S&P Small-Cap ETF
IJR
$113B
| $8.14M | 0.18% |
74,990
-12,755
| -15% | -$1.34M |
|
130
WSFS Financial
WSFS
$4.24B
| $7.94M | 0.18% |
159,455
-85,647
| -35% | -$4.12M |
|
131
Ring Energy
REI
$310M
| $7.22M | 0.16% |
3,127,399
+36,024
| +1% | +$68.6K |
|
132
Fulton Financial
FULT
$4.77B
| $6.33M | 0.14% |
371,860
-50,979
| -12% | -$789K |
|
|
CCEC
133
Capital Clean Energy Carriers
CCEC
$1.36B
| $5.02M | 0.11% |
451,273
-4,744
| -1% | -$47.1K |
|
|
134
Diamondback Energy
FANG
$52.1B
| $4.96M | 0.11% |
+67,482
| New | +$4.62M |
|
|
FFIC
135
DELISTED
Flushing Financial
FFIC
| $3.95M | 0.09% |
+186,245
| New | +$3.85M |
|
|
DSSI
136
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $3.58M | 0.08% |
357,159
+3,460
| +1% | +$28.1K |
|
|
BMTX
137
DELISTED
BM Technologies, Inc.
BMTX
| $2.03M | 0.05% |
+174,452
| New | +$2.37M |
|
138
iShares Core S&P Mid-Cap ETF
IJH
$126B
| – | – |
-50
| Closed | -$2K |
|
139
RPC Inc
RES
$1.28B
| – | – |
-996,077
| Closed | -$3.14M |
|
|
QEP
140
DELISTED
QEP RESOURCES, INC.
QEP
| – | – |
-1,530,430
| Closed | -$3.66M |
|
Similar funds
SCI
GCP
BW
HH
KCM
SCM
PRA
CC
Aristotle Capital Boston's Q1 2021 Portfolio in Review
As of Q1 2021, Aristotle Capital Boston held 140 positions worth $4.49B, up 6.5% from $4.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Aristotle Capital Boston withdrew a net $202M in Q1 2021, closing 3 positions and reducing 95 holdings. Its most notable exit was QEP RESOURCES, INC., an estimated $3.66M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Aristotle Capital Boston opened a new position in eHealth worth $24.6M.
- Aristotle Capital Boston's largest Q1 2021 buy was eHealth: 338,806 shares worth $24.6M.
- Aristotle Capital Boston added most to Coherus Oncology in Q1 2021, an estimated $5.41M increase.
- Aristotle Capital Boston's biggest Q1 2021 reduction was Evercore, cutting an estimated $19.7M.
- Aristotle Capital Boston fully exited QEP RESOURCES, INC. in Q1 2021, selling an estimated $3.66M.
- Aristotle Capital Boston's ten largest holdings make up 17% of its $4.49B portfolio in Q1 2021.
- Aristotle Capital Boston opened 5 new positions and closed 3 in Q1 2021.
- Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $4.49B.
Based on Aristotle Capital Boston's 13F filing for Q1 2021, filed 17 May 2021.